Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8661)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes 2014; 5(5): 586-600 [PMID: 25317237 DOI: 10.4239/wjd.v5.i5.586] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i5/586.htm |
| Number | Citing Articles |
| 1 |
Maher BM. Boraie, Yasser A. Elnaggar, Mohammed Othman Ahmed, Ahmed M. Mahmoud. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2641 doi: 10.1016/j.dsx.2019.07.032
|
| 2 |
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
|
| 3 |
Mahyar Mohammadifard, Masood Ziaee, Gholamreza Sharifzadeh, Toba Kazemi, Zohreh Azarkar, Mahboubeh Saljoughi, Azadeh Ebrahimzadeh. Evaluation of Liver Enzyme Elevation and Its Contributing Factors in Birjand, Iran. Modern Care Journal 2017; 14(4) doi: 10.5812/modernc.68238
|
| 4 |
Silvia Fabiani, Poupak Fallahi, Silvia Martina Ferrari, Mario Miccoli, Alessandro Antonelli. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Reviews in Endocrine and Metabolic Disorders 2018; 19(4): 405 doi: 10.1007/s11154-017-9440-1
|
| 5 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0976-x
|
| 6 |
Parimala Narne. Impaired insulin exocytosis in chronic hepatitis C infection: contributory role of p38δ MAPK–protein kinase D–golgi complex axis. Clinical Science 2020; 134(12): 1449 doi: 10.1042/CS20200686
|
| 7 |
Satoru Oji, Eva-Maria Nicolussi, Nathalie Kaufmann, Bleranda Zeka, Kathrin Schanda, Kazuo Fujihara, Zsolt Illes, Charlotte Dahle, Markus Reindl, Hans Lassmann, Monika Bradl, Orhan Aktas. Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord. PLOS ONE 2016; 11(3): e0151244 doi: 10.1371/journal.pone.0151244
|
| 8 |
Sita Sharan Patel, Malairaman Udayabanu. Effect of natural products on diabetes associated neurological disorders. Reviews in the Neurosciences 2017; 28(3): 271 doi: 10.1515/revneuro-2016-0038
|
| 9 |
Jason T. Blackard, Ling Kong, Angela Lombardi, Dirk Homann, Sara Salehi Hammerstad, Yaron Tomer. A preliminary analysis of hepatitis C virus in pancreatic islet cells. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0905-3
|
| 10 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10): 453 doi: 10.1111/1348-0421.13023
|
| 11 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1): 23 doi: 10.3390/biology12010023
|
| 12 |
Ignazio Grattagliano, Alessandro Rossi, Ettore Marconi, Francesco Lapi, Claudio Cricelli. Determinants of HCV‐related complications in Italian primary care patients. Liver International 2021; 41(12): 2857 doi: 10.1111/liv.15017
|
| 13 |
Saruar Alam, Md. Kamrul Hasan, Sharif Neaz, Nazmul Hussain, Md. Faruk Hossain, Tania Rahman. Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management. Diabetology 2021; 2(2): 36 doi: 10.3390/diabetology2020004
|
| 14 |
Maria Stepanova, Linda Henry, Rishi Garg, Shirley Kalwaney, Sammy Saab, Zobair Younossi. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0407-y
|
| 15 |
Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights 2024; 15(3): 676 doi: 10.3390/gastroent15030049
|
| 16 |
Elise J. Smolders, Angela Colbers, Clara T. M. M. de Kanter, Kirsten Velthoven‐Graafland, Leonie T. Wolberink, Noor van Ewijk‐Beneken Kolmer, Joost P. H. Drenth, Rob E. Aarnoutse, Cees J. Tack, David M. Burger. Metformin and daclatasvir: absence of a pharmacokinetic–pharmacodynamic drug interaction in healthy volunteers. British Journal of Clinical Pharmacology 2017; 83(10): 2225 doi: 10.1111/bcp.13323
|
| 17 |
Masood Ziaee, Mahboubeh Saljoughi, Forough Fardinfar, Farah Madarshahian, Azadeh Ebrahimzadeh. Comparison of Frequency Distribution of Diabetes in Hepatitis B and C Patients and Other People in Birjand. Modern Care Journal 2021; 18(1) doi: 10.5812/modernc.111024
|
| 18 |
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang. TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes. Journal of the Formosan Medical Association 2023; 122(3): 202 doi: 10.1016/j.jfma.2023.01.011
|
| 19 |
Mahmoud Abdo, Ahmed Rabiee, Zeinab Abdellatif, Shereen Abdel Alem, Ahmed Moustafa. Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1588 doi: 10.1097/MEG.0000000000001903
|
| 20 |
Lee-Moay Lim, Jer-Ming Chang, Hung-Tien Kuo. Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes. Biomedicines 2023; 11(2): 470 doi: 10.3390/biomedicines11020470
|
| 21 |
Frank C. Mooren, Anne-Bettina Streblow. Prävention und Therapie durch Sport, Band 4. 2016; : 319 doi: 10.1016/B978-3-437-24285-4.00011-2
|
| 22 |
Halina White. Gastrointestinal Disorders and the Nervous System. CONTINUUM: Lifelong Learning in Neurology 2020; 26(3): 577 doi: 10.1212/CON.0000000000000871
|
| 23 |
Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort). Journal of Viral Hepatitis 2020; 27(12): 1473 doi: 10.1111/jvh.13380
|
| 24 |
Susanna Dunachie, Parinya Chamnan. The double burden of diabetes and global infection in low and middle-income countries. Transactions of The Royal Society of Tropical Medicine and Hygiene 2019; 113(2): 56 doi: 10.1093/trstmh/try124
|
| 25 |
Anna Licata, Giuseppina T. Russo, Annalisa Giandalia, Marcella Cammilleri, Clelia Asero, Irene Cacciola. Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes. Journal of Personalized Medicine 2023; 13(3): 558 doi: 10.3390/jpm13030558
|
| 26 |
Muneerah Hamad Aldubaie, Prarthana M. Suryavamshi, Uma M. Irfan, Hamad A. Al-Hamed, Turki Abdullah Almogbel, Ahmad Almatroudi, Faris Alrumaihi, Khaled Allemailem. Prevalence of Hepatitis C Viral Infection among Diabetes Mellitus Patients in Qassim Region, Saudi Arabia. Journal of Pure and Applied Microbiology 2023; 17(3): 1722 doi: 10.22207/JPAM.17.3.37
|
| 27 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 28 |
Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?. Biomedicines 2022; 10(3): 534 doi: 10.3390/biomedicines10030534
|
| 29 |
George N. Ioannou, Jordan J. Feld. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?. Gastroenterology 2019; 156(2): 446 doi: 10.1053/j.gastro.2018.10.033
|
| 30 |
Haijiang Wu, Xinna Deng, Yonghong Shi, Ye Su, Jinying Wei, Huijun Duan. PGC-1α, glucose metabolism and type 2 diabetes mellitus. Journal of Endocrinology 2016; 229(3): R99 doi: 10.1530/JOE-16-0021
|
| 31 |
Sunil Taneja, Sunil Tohra, Ajay Duseja, Radha Krishan Dhiman, Yogesh Kumar Chawla. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C—An Experience from a Tertiary Care Hospital. Journal of Clinical and Experimental Hepatology 2016; 6(4): 282 doi: 10.1016/j.jceh.2016.08.001
|
| 32 |
Amer Rajab, Jill Buss, Phil A. Hart, Darwin Conwell, Luis Lara, Shumei Meng, Kristin Kuntz, Sylvester Black, Ken Washburn. Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection. Cell Transplantation 2018; 27(10): 1569 doi: 10.1177/0963689718796772
|
| 33 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis. Dubai Diabetes and Endocrinology Journal 2018; 24(1-4): 29 doi: 10.1159/000493945
|
| 34 |
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro‐cardiovascular disease: analysis of a national population‐based survey in Egypt. Tropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
|
| 35 |
Oleksandra Ya. Pryshliak, Larysa Ye. Kovalchuk, Oleksandra V. Marynchak, Oleksandr P. Boichuk, Ihor H. Hryzhak, Oksana Ye. Kondryn, Valentyna F. Piuryk. FUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES’ GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE II. Wiadomości Lekarskie 2020; 73(8): 1671 doi: 10.36740/WLek202008116
|
| 36 |
Anna Onisiforou, Panos Zanos. One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders. Computational and Structural Biotechnology Journal 2024; 23: 3610 doi: 10.1016/j.csbj.2024.10.011
|
| 37 |
Ruchi Roy, Raj Singh, Sasha H. Shafikhani. The Diabetic Foot. Contemporary Diabetes 2024; : 299 doi: 10.1007/978-3-031-55715-6_17
|
| 38 |
Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri. Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals. F1000Research 2022; 11: 649 doi: 10.12688/f1000research.109397.1
|
| 39 |
Chao Yang, Min Wan, Yifei Lu, Xian Yang, Ligang Yang, Shaokang Wang, Guiju Sun. Associations between diabetes mellitus and the risk of hepatocellular carcinoma in Asian individuals with hepatitis B and C infection: systematic review and a meta-analysis of cohort studies. European Journal of Cancer Prevention 2022; 31(2): 107 doi: 10.1097/CEJ.0000000000000669
|
| 40 |
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
|
| 41 |
Kanwal Ilyas, Saba Zahid, Madeeha Batool, Aqif Anwar Chaudhry, Arshad Jamal, Farasat Iqbal, Mian Hasnain Nawaz, Oliver Goerke, Aleksander Gurlo, Asma Tufail Shah, Ihtesham ur Rehman. In-vitro investigation of graphene oxide reinforced bioactive glass ceramics composites. Journal of Non-Crystalline Solids 2019; 505: 122 doi: 10.1016/j.jnoncrysol.2018.10.047
|
| 42 |
Lohanna STRAUHS-NITSCH, Marcela Ferro CAMPIOLO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Claudia Alexandre Pontes IVANTES. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR. Arquivos de Gastroenterologia 2020; 57(3): 267 doi: 10.1590/s0004-2803.202000000-50
|
| 43 |
Suliman M. Al Humayed, Ahmed A. Mahfouz, Nabil J. Awadalla, Abdullah A. Alsabaani. Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor?. International Journal of Environmental Research and Public Health 2018; 15(11): 2513 doi: 10.3390/ijerph15112513
|
| 44 |
Anupam Bapu Jena, Julia Thornton Snider, Oliver Diaz Espinosa, Andy Ingram, Yuri Sanchez Gonzalez, Darius Lakdawalla. How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?. Value in Health 2019; 22(6): 669 doi: 10.1016/j.jval.2018.09.2923
|
| 45 |
Chrysovalantou Mihailidou, Athanasios G. Papavassiliou, Hippokratis Kiaris.
Retracted: Cell‐autonomous cytotoxicity of type I interferon response
via
induction of endoplasmic reticulum stress
. The FASEB Journal 2017; 31(12): 5432 doi: 10.1096/fj.201700152R
|
| 46 |
Ashish K. Rehni, Allen Liu, Miguel A. Perez-Pinzon, Kunjan R. Dave. Diabetic aggravation of stroke and animal models. Experimental Neurology 2017; 292: 63 doi: 10.1016/j.expneurol.2017.03.004
|
| 47 |
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case series. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
|
| 48 |
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
|
| 49 |
Chalermrat Bunchorntavakul, Monthira Maneerattanaporn, Disaya Chavalitdhamrong. Management of patients with hepatitis C infection and renal disease. World Journal of Hepatology 2015; 7(2): 213-225 doi: 10.4254/wjh.v7.i2.213
|
| 50 |
Kenneth A. Lichtenstein, Rachel L. D. Hart, Kathleen C. Wood, Samuel Bozzette, Kate Buchacz, John T. Brooks. Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 69(3): 306 doi: 10.1097/QAI.0000000000000581
|
| 51 |
Stefania Kokkali, Isabelle Oddou, Justine Gantzer, Aikaterini Fitsiori. Human herpesvirus 6 encephalitis in a patient treated with everolimus for renal cell carcinoma. Journal of Oncology Pharmacy Practice 2020; 26(8): 2052 doi: 10.1177/1078155220918022
|
| 52 |
Xi-Ding Yang, Yong-Yu Yang. Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.853822
|
| 53 |
Y. Morán-Auth, M. Penna-Martinez, D. Perner, S. Susser, S. Wicker, S. Zeuzem, C. Sarrazin, K. Badenhoop. IL28B gene variants and glucose metabolism in Type 2 Diabetes. Human Immunology 2016; 77(12): 1280 doi: 10.1016/j.humimm.2016.09.007
|
| 54 |
Barbara Kronsteiner, Panjaporn Chaichana, Manutsanun Sumonwiriya, Kemajitra Jenjaroen, Fazle Rabbi Chowdhury, Suchintana Chumseng, Prapit Teparrukkul, Direk Limmathurotsakul, Nicholas P.J. Day, Paul Klenerman, Susanna J. Dunachie. Diabetes alters immune response patterns to acute melioidosis in humans. European Journal of Immunology 2019; 49(7): 1092 doi: 10.1002/eji.201848037
|
| 55 |
Ben Niu, Xueshan Xia, Lijing Ma, Lixuan Yao, Yating Zhang, Heng Su, Yun Ping Lim. LncRNA AC040162.3 Promotes HCV-Induced T2DM Deterioration through the miRNA-223-3p/NLRP3 Molecular Axis. Analytical Cellular Pathology 2023; 2023: 1 doi: 10.1155/2023/5350999
|
| 56 |
Jialing Li, Luxin Li, Zhen Zhang, Peijian Chen, Haiying Shu, Can Yang, Yanhui Chu, Jieting Liu. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1294317
|
| 57 |
Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis. Indian Journal of Medical Research 2020; 152(6): 562 doi: 10.4103/ijmr.IJMR_1088_18
|
| 58 |
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0241-4
|
| 59 |
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2. Metabolism 2024; 156: 155917 doi: 10.1016/j.metabol.2024.155917
|
| 60 |
Gautam Das, Hemanth Bolusani. Hepatitis C virus infection and diabetes. Practical Diabetes 2016; 33(4): 123 doi: 10.1002/pdi.2017
|
| 61 |
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4. Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
|
| 62 |
C Cheng Kao, Guanghui Yi, Hsuan-Cheng Huang. The core of hepatitis C virus pathogenesis. Current Opinion in Virology 2016; 17: 66 doi: 10.1016/j.coviro.2016.01.009
|
| 63 |
Hany Aly Hussein, Ahmed Samir Allam, Ahmed Samir Abdel Moaty. Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir. Current Diabetes Reviews 2020; 16(2): 165 doi: 10.2174/1573399815666190531091128
|
| 64 |
Raymond Anthony Pashun, Nicole T. Shen, Arun Jesudian. Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C. Case Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/7807921
|
| 65 |
Cheng-Yi Chen, Cheng-Jui Lin, Chih-Sheng Lin, Fang-Ju Sun, Chi-Feng Pan, Han-Hsiang Chen, Chih-Jen Wu. The prevalence and association of chronic kidney disease and diabetes in liver cirrhosis using different estimated glomerular filtration rate equation. Oncotarget 2018; 9(2): 2236 doi: 10.18632/oncotarget.23368
|
| 66 |
Ayush Jain, Bhupinder Singh Kalra, Siddharth Srivastava, Shalini Chawla. Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients. Indian Journal of Gastroenterology 2019; 38(1): 39 doi: 10.1007/s12664-019-00935-w
|
| 67 |
R Pippi, U Romeo, M Santoro, A Del Vecchio, C Scully, S Petti. Psychological disorders and oral lichen planus: matched case–control study and literature review. Oral Diseases 2016; 22(3): 226 doi: 10.1111/odi.12423
|
| 68 |
Ying Chen, Hanzhen Ji, Jianguo Shao, Yulong Jia, Qi Bao, Jianan Zhu, Lei Zhang, Yi Shen. Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis. Digestive Diseases and Sciences 2020; 65(7): 1940 doi: 10.1007/s10620-019-05918-7
|
| 69 |
Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco. The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm. Journal of Clinical Medicine 2020; 9(2): 563 doi: 10.3390/jcm9020563
|
| 70 |
P. A. Beliy, K. R. Dudina, O. O. Znoyko, T. N. Markova, I. A. Morozova, N. P. Blokhina, E. A. Nurmukhametova, N. D. Yushchuk. Prevalence of chronic HCV infection in patients with type 2 diabetes mellitus in Russia. Diabetes mellitus 2022; 25(1): 4 doi: 10.14341/DM12847
|
| 71 |
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis. Acta Diabetologica 2019; 56(3): 341 doi: 10.1007/s00592-018-1257-1
|
| 72 |
Justine Hum, Janice H. Jou, Pamela K. Green, Kristin Berry, James Lundblad, Barbara D. Hettinger, Michael Chang, George N. Ioannou. Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus. Diabetes Care 2017; 40(9): 1173 doi: 10.2337/dc17-0485
|
| 73 |
EL Shaimaa Gomaa Ali, Rasha H. Bassyouni, Omayma O. Abdelaleem, Essam A. Hassan, Sylvana N. Gaber. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients. Virus Research 2022; 310: 198684 doi: 10.1016/j.virusres.2022.198684
|
| 74 |
Jucéli Márcia Hendges Sparvoli, Antonio Cardoso Sparvoli, Samuel de Carvalho Dumith, Afonso Alexandre Pereira, Ana Luisa Machado de Paula, Laís Garcia, Vanusa Belarmino, Vanusa Pousada da Hora, Ana Maria Barral de Martínez, Carla Vitola Gonçalves. Impact of hepatitis C virus eradication with direct-acting antivirals on glycidic metabolism. Archives of Endocrinology and Metabolism 2022; doi: 10.20945/2359-3997000000543
|